Skip to main content
Log in

Acetylsalicylsäure zur Prävention kolorektaler Adenome

Die APP-Studie

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Provenzale D (2002) The cost-effectiveness of aspirin for chemoprevention of colorectal cancer. Gastroenterology 122: 230—233

    PubMed  Google Scholar 

  2. Sandler RS, Halabi S, Baron JA et al. (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348: 883—890

    Article  CAS  PubMed  Google Scholar 

  3. Steinbach G, Lynch P, Phillips R et al. (2000) The effect of celecoxib, a cyclooxygenase-2-inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 1946—1952

    CAS  PubMed  Google Scholar 

  4. Thun MJ, Namboodiri MM, Heath CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593—1596

    Google Scholar 

  5. Winawer SJ, Zauber AG, O'Brien MJ et al. (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328: 901—906

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Schmiegel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmiegel, W., Reinacher-Schick, A. Acetylsalicylsäure zur Prävention kolorektaler Adenome. Internist 44, 1322–1324 (2003). https://doi.org/10.1007/s00108-003-1033-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-003-1033-2

Navigation